← Back to all earnings calls

Enanta Pharmaceuticals Inc Q3 FY2020 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2020 Q3 Call date: 2020-08-04 Concluded

Share

Quarter scorecard

Revenue

$18.65M

-58% YoY

Diluted EPS

$-0.71

-315.2% YoY

Net income

-$14.27M

-302.7% YoY

Documents & deck